Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FM8R7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,210
Award facts
- Contract value 100% obligated
- $41,210.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,210.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on January 2, 2026, with a completion date of January 5, 2026. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, one of the federal government's primary vendors for medical supply procurement. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems. The company's consistent receipt of competitively awarded delivery orders with firm fixed pricing—ranging from nominal amounts to orders exceeding $45,000—reflects its capability to meet federal medical procurement requirements. As DLA Troop Support develops the next generation of Pharmaceutical Prime Vendor Global Program contracts with plans for multiple regional awards, AmerisourceBergen remains positioned as a critical supplier within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM8R7?
SPE2DR26FM8R7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FM8R7 worth?
The government has obligated $41,210 on SPE2DR26FM8R7.
Is contract SPE2DR26FM8R7 an order under another contract?
Yes. SPE2DR26FM8R7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8R7 competed?
The extent of competition for SPE2DR26FM8R7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award